China Resources Double-Crane Pharmaceutical Co.,Ltd. Stock Price

SHSE:600062 Community·CN¥17.2b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
1 Fair Values set on narratives written by author

Create Narrative

600062 Share Price Performance

CN¥16.46

-2.20 (-11.79%)

CN¥16.46

-2.20 (-11.79%)

CN¥16.46

Thu, 25 Jun 26

Share Pricen/a

600062 Community Narratives

There are no narratives available yet.

Create Narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Excellent balance sheet established dividend payer.

1 Risk

4 Rewards

View Full Analysis

China Resources Double-Crane Pharmaceutical Co.,Ltd. Key Details

Last Reported Earnings

Mar 31, 2026

Next Reporting Earnings

n/a

: 1.57
: 57.18%
: 15.15%
: 12.8%

View Full Analysis

About 600062

Founded: 1939
Employees: 13184
CEO: Qian Zhao
WebsiteView website: www.dcpc.com

China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a pharmaceutical company in the People’s Republic of China. The company offers pharmaceutical products for blood pressure and sugar, injections, lipid-lowering, pediatrics, nephrology, API, pharmaceutical, psychiatry/neurology, inflammation, anticoagulation, oncology, women's health, anesthesia, and analgesia. The company was founded in 1939 and is headquartered in Beijing, the People’s Republic of China. China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a subsidiary of Beijing Pharmaceutical Group Co., Ltd.